MPO and idiopathic pulmonary fibrosis: Therefore, we will expand our sample size in future studies and combine the detection of MPO-DNA, Cit-H3, RF, and anti-CCP antibodies for the differential diagnosis of clinical RA-NSIP and RA-UIP patients, which may result in personalized treatment in clinical settings.